BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 15386719)

  • 1. Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).
    Sever JL; Brenner AI; Gale AD; Lyle JM; Moulton LH; Ward BJ; West DJ
    Pharmacoepidemiol Drug Saf; 2004 Dec; 13(12):825-40. PubMed ID: 15386719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).
    Sever JL; Brenner AI; Gale AD; Lyle JM; Moulton LH; West DJ;
    Pharmacoepidemiol Drug Saf; 2002; 11(3):189-202. PubMed ID: 12051118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007.
    Niu MT; Ball R; Woo EJ; Burwen DR; Knippen M; Braun MM;
    Vaccine; 2009 Jan; 27(2):290-7. PubMed ID: 18992783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal adverse reactions following anthrax vaccination: an analysis of the Vaccine Adverse Events Reporting System (VAERS) database.
    Geier MR; Geier DA
    Hepatogastroenterology; 2004; 51(57):762-7. PubMed ID: 15143911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003.
    McMahon AW; Iskander J; Haber P; Chang S; Woo EJ; Braun MM; Ball R
    Pediatrics; 2005 Feb; 115(2):453-60. PubMed ID: 15687455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative assessment of immunization records in the Defense Medical Surveillance System and the Vaccine Adverse Event Reporting System.
    McNeil MM; Ma G; Aranas A; Payne DC; Rose CE
    Vaccine; 2007 Apr; 25(17):3428-36. PubMed ID: 17258846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006.
    Chang S; Ball R; Braun MM
    Vaccine; 2008 May; 26(19):2428-32. PubMed ID: 18406499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse events after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine administered to adults 65 years of age and older reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2010.
    Moro PL; Yue X; Lewis P; Haber P; Broder K
    Vaccine; 2011 Nov; 29(50):9404-8. PubMed ID: 21920404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of adverse events reported by participants in CDC's anthrax vaccine and antimicrobial availability program.
    Martin SW; Tierney BC; Aranas A; Rosenstein NE; Franzke LH; Apicella L; Marano N; McNeil MM
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):393-401. PubMed ID: 15717323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse event reports following yellow fever vaccination.
    Lindsey NP; Schroeder BA; Miller ER; Braun MM; Hinckley AF; Marano N; Slade BA; Barnett ED; Brunette GW; Horan K; Staples JE; Kozarsky PE; Hayes EB
    Vaccine; 2008 Nov; 26(48):6077-82. PubMed ID: 18809449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety review of the purified chick embryo cell rabies vaccine: Data from the Vaccine Adverse Event Reporting System (VAERS), 1997-2005.
    Dobardzic A; Izurieta H; Woo EJ; Iskander J; Shadomy S; Rupprecht C; Ball R; Braun MM
    Vaccine; 2007 May; 25(21):4244-51. PubMed ID: 17382435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of military and civilian reporting rates for smallpox vaccine adverse events.
    McMahon AW; Zinderman C; Ball R; Gupta G; Braun MM
    Pharmacoepidemiol Drug Saf; 2007 Jun; 16(6):597-604. PubMed ID: 17154344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases.
    Coté TR; Mohan AK; Polder JA; Walton MK; Braun MM
    J Am Acad Dermatol; 2005 Sep; 53(3):407-15. PubMed ID: 16112345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007 [Vaccine 2009;27:290-297].
    Niu M; Ball R
    Vaccine; 2009 Nov; 27(48):6654-5. PubMed ID: 19716457
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccine.
    Block SL; Brown DR; Chatterjee A; Gold MA; Sings HL; Meibohm A; Dana A; Haupt RM; Barr E; Tamms GM; Zhou H; Reisinger KS
    Pediatr Infect Dis J; 2010 Feb; 29(2):95-101. PubMed ID: 19952863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of body mass index, pre-vaccination serum progesterone levels and anti-anthrax protective antigen immunoglobulin G on injection site adverse events following anthrax vaccination in women.
    Zhang Y; Martin SW; Rose CE; Biagini RE; Franzke LH; Smith JP; Sammons DL; Robertson SA; McNeil MM
    Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1060-7. PubMed ID: 18781705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus vaccine safety in pediatric patients: an evaluation of the Vaccine Adverse Event Reporting System.
    Borja-Hart NL; Benavides S; Christensen C
    Ann Pharmacother; 2009 Feb; 43(2):356-9. PubMed ID: 19155346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmarketing safety surveillance for typhoid fever vaccines from the Vaccine Adverse Event Reporting System, July 1990 through June 2002.
    Begier EM; Burwen DR; Haber P; Ball R;
    Clin Infect Dis; 2004 Mar; 38(6):771-9. PubMed ID: 14999618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term reactogenicity and gender effect of anthrax vaccine: analysis of a 1967-1972 study and review of the 1955-2005 medical literature.
    McNeil MM; Chiang IS; Wheeling JT; Zhang Y
    Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):259-74. PubMed ID: 17245803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.